Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
1.450
+0.020 (1.40%)
Aug 25, 2026, 10:55 AM EST
Interpace Biosciences Earnings Call Transcripts
Fiscal Year 2026
-
The meeting confirmed quorum and approved all seven proposals, including board declassification, new equity plans, and auditor ratification. Strategic priorities include relaunching a pancreatic cancer test, expanding the product portfolio, and investing in research and lab automation.